Event Brief
Nov 30, 2025 at 8:05 PM ET
Celltrion biosimilar added to U.S. drug lists
By The BriefBrief
Celltrion's biosimilar has been included in two preferred drug lists in the U.S.
WHO: Celltrion Inc.
WHAT: Biosimilar added to preferred drug lists
WHEN: Nov 30, 2025 at 7:00 PM ET
WHERE: United States
WHY: To expand access to biopharmaceuticals
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia
May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21447 of 21447
Same format. Every time.
Continue reading — sign in or create a free account with
